234 related articles for article (PubMed ID: 23007467)
1. Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy.
Lee MH; Choi EN; Jeon YJ; Jung SC
Int J Mol Med; 2012 Dec; 30(6):1275-80. PubMed ID: 23007467
[TBL] [Abstract][Full Text] [Related]
2. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis.
Ferrari G; Pintucci G; Seghezzi G; Hyman K; Galloway AC; Mignatti P
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17260-5. PubMed ID: 17088559
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis.
Rozenfeld PA; de Los Angeles Bolla M; Quieto P; Pisani A; Feriozzi S; Neuman P; Bondar C
Mol Genet Metab; 2020 Feb; 129(2):132-141. PubMed ID: 31718986
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis.
Ferrari G; Cook BD; Terushkin V; Pintucci G; Mignatti P
J Cell Physiol; 2009 May; 219(2):449-58. PubMed ID: 19180561
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.
Tuttolomondo A; Simonetta I; Riolo R; Todaro F; Di Chiara T; Miceli S; Pinto A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576250
[TBL] [Abstract][Full Text] [Related]
6. Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells.
Do HS; Park SW; Im I; Seo D; Yoo HW; Go H; Kim YH; Koh GY; Lee BH; Han YM
EBioMedicine; 2020 Feb; 52():102633. PubMed ID: 31981984
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic pathways of renal damage in Fabry nephropathy: interplay between immune cell infiltration, apoptosis and fibrosis.
Bondar C; de Bolla MLA; Neumann P; Pisani A; Feriozzi S; Rozenfeld PA
J Nephrol; 2024 Apr; 37(3):625-634. PubMed ID: 38512375
[TBL] [Abstract][Full Text] [Related]
8. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.
Sanchez-Niño MD; Sanz AB; Carrasco S; Saleem MA; Mathieson PW; Valdivielso JM; Ruiz-Ortega M; Egido J; Ortiz A
Nephrol Dial Transplant; 2011 Jun; 26(6):1797-802. PubMed ID: 20504837
[TBL] [Abstract][Full Text] [Related]
9. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
10. Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy.
Ivanova MM; Dao J; Slayeh OA; Friedman A; Goker-Alpan O
Cells; 2023 Aug; 12(16):. PubMed ID: 37626912
[TBL] [Abstract][Full Text] [Related]
11. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
[TBL] [Abstract][Full Text] [Related]
12. Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells.
Boström K; Zebboudj AF; Yao Y; Lin TS; Torres A
J Biol Chem; 2004 Dec; 279(51):52904-13. PubMed ID: 15456771
[TBL] [Abstract][Full Text] [Related]
13. Fuxin Granules ameliorate diabetic nephropathy in db/db mice through TGF-β1/Smad and VEGF/VEGFR2 signaling pathways.
Zheng W; Qian C; Xu F; Cheng P; Yang C; Li X; Lu Y; Wang A
Biomed Pharmacother; 2021 Sep; 141():111806. PubMed ID: 34246190
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction.
Bige N; Shweke N; Benhassine S; Jouanneau C; Vandermeersch S; Dussaule JC; Chatziantoniou C; Ronco P; Boffa JJ
Kidney Int; 2012 Jun; 81(12):1226-38. PubMed ID: 22418977
[TBL] [Abstract][Full Text] [Related]
15. Globotriaosylceramide-induced reduction of K
Rickert V; Kramer D; Schubert AL; Sommer C; Wischmeyer E; Üçeyler N
Exp Neurol; 2020 Feb; 324():113134. PubMed ID: 31778662
[TBL] [Abstract][Full Text] [Related]
16. Enamel matrix derivative induces production of vascular endothelial cell growth factor in human gingival fibroblasts.
Sakoda K; Nakajima Y; Noguchi K
Eur J Oral Sci; 2012 Dec; 120(6):513-9. PubMed ID: 23167467
[TBL] [Abstract][Full Text] [Related]
17. Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease.
Shin YJ; Jeon YJ; Jung N; Park JW; Park HY; Jung SC
Mol Med Rep; 2015 Oct; 12(4):5049-57. PubMed ID: 26135632
[TBL] [Abstract][Full Text] [Related]
18. Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease.
Ishii S; Taguchi A; Okino N; Ito M; Maruyama H
J Biol Chem; 2020 Apr; 295(17):5577-5587. PubMed ID: 32179651
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5.
Lu Q
Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L123-33. PubMed ID: 18456797
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for globotriaosylceramide regulation and enzyme uptake in immortalized aortic endothelial cells from Fabry mice.
Meng XL; Day TS; McNeill N; Ashcraft P; Frischmuth T; Cheng SH; Liu ZP; Shen JS; Schiffmann R
J Inherit Metab Dis; 2016 May; 39(3):447-455. PubMed ID: 26960552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
